John Kevin John, Nabzdyk Christoph G S, Chweich Haval, Mishra Ajay Kumar, Lal Amos
Department of Medicine, Tufts Medical Center, Boston, MA, USA.
Biomedical Innovation and Translation, Critical Care & Cardiac Anesthesia, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Ann Transl Med. 2024 Feb 1;12(1):14. doi: 10.21037/atm-23-1734. Epub 2023 Dec 4.
The ProtekDuo (LivaNova, London, UK) cannula is a dual-lumen device, typically inserted into the right internal jugular (IJ) vein through a percutaneous approach, with fluoroscopy or ultrasound guidance. When connected to a pump, such as the TandemHeart (LivaNova, London, UK) or CentriMag (Abbott, Pleasanton, CA, USA), it can function as a right ventricular (RV) mechanical circulatory support (MCS). When an oxygenator is also added [veno-pulmonary (V-P)], it can provide extracorporeal membrane oxygenation (ECMO) support. This review aims to provide a comprehensive overview of the device's physiology and clinical applications. In the setting of RV failure (RVF), the ProtekDuo cannula, with its outflow in the main pulmonary artery (PA), can bypass the failing RV, improving pulmonary flow, left atrial (LA) filling pressures, and left ventricular (LV) preload. This can also reduce ventricular interdependence and leftward shift of the interventricular septum that occurs in RVF. In this review, the key sections expand on the use of the ProtekDuo cannula in the management of critically ill patients, specifically, the use of ProtekDuo for RV myocardial infarction (MI) RVF, LV assist device (LVAD) implantation-associated RVF, RVF post-heart transplantation, temporary biventricular MCS as bridge to recovery (ECpella 2.0 or PROpella), biventricular support as bridge to recovery or decision, isolated LV failure, post lung transplantation (LT) care, and other miscellaneous clinical scenarios. ProtekDuo is an important tool in the armory of RVF management. The ProtekDuo system is expected to gain more popularity given its clear advantages such as groin-free approach allowing for mobility, easy percutaneous deployment, compatibility with various pumps and oxygenators, and the versatility to be integrated in numerous configurations. In an era of expanding MCS options, further research is needed to better understand the optimal tool for specific patient subsets.
ProtekDuo(英国伦敦LivaNova公司)套管是一种双腔装置,通常在透视或超声引导下经皮穿刺插入右颈内静脉。当与诸如TandemHeart(英国伦敦LivaNova公司)或CentriMag(美国加利福尼亚州普莱森顿雅培公司)等泵连接时,它可作为右心室机械循环支持(MCS)发挥作用。当增加一个氧合器[静脉 - 肺(V - P)]时,它可提供体外膜肺氧合(ECMO)支持。本综述旨在全面概述该装置的生理学及临床应用。在右心室衰竭(RVF)的情况下,流出端位于主肺动脉(PA)的ProtekDuo套管可绕过衰竭的右心室,改善肺血流、左心房(LA)充盈压和左心室(LV)前负荷。这也可减少RVF时出现的心室相互依赖及室间隔向左移位。在本综述中,关键部分详细阐述了ProtekDuo套管在危重症患者管理中的应用,具体包括ProtekDuo用于右心室心肌梗死(MI)合并RVF、左心室辅助装置(LVAD)植入相关的RVF、心脏移植术后RVF、作为恢复桥梁的临时双心室MCS(ECpella 2.0或PROpella)、作为恢复或决策桥梁的双心室支持、孤立性左心室衰竭、肺移植(LT)术后护理以及其他各种临床情况。ProtekDuo是RVF管理手段中的一项重要工具。鉴于ProtekDuo系统具有诸多明显优势,如无需经腹股沟途径从而便于活动、易于经皮置入、与各种泵和氧合器兼容以及能以多种配置集成的多功能性,预计它将更受欢迎。在机械循环支持选项不断增加的时代,需要进一步研究以更好地了解针对特定患者亚组的最佳工具。